|Articles|June 11, 2021
Analytical instrument portfolio for clinical diagnostics
Thermo Scientific’s Medical Device (MD) portfolio of liquid chromatography-mass spectrometry (LC–MS) systems comprises of United States Food and Drug Administration (U.S. FDA) Class I medical devices, including the Vanquish MD High Performance Liquid Chromatography (HPLC) system, TSQ Altis MD Series mass spectrometer and Quantis MD Series mass spectrometer. According to the company, the systems are designed to increase throughput of clinical diagnostic assays for the detection of small to large molecules within complex biological matrices.
Thermo Fisher Scientific, San Jose, CA
Trending on LCGC International
1
HILIC vs Reversed-Phase LC for Central Carbon Metabolism Profiling
2
LC-MS/MS Links Vitamin D Levels to Sleep Timing
3
Analytical Procedure Lifecycle Approaches in Accordance With ICH Q14 and ICH Q2(R2): Opportunity Knocks or Just Another Challenge and Headache? (Part 2)
4
Highlights from the HPLC2026 Conference through the Lens of LC Troubleshooting
5